Clinical
Discover results-proven tools and methodologies for your clinical development. Learn how to improve your trial design, data collection and clinical supply. In addition, get key information on how to improve your patient recruitment and retention. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in clinical development to exchange ideas on best practice and share case studies on innovation within the area.
The AI-Powered Path to Revolutionising Rare Disease Research
February 23 by Joanna EdwardsExplore how AI/ML can accelerate rare disease research and clinical trials, by enhancing inclusivity and efficiency, to deliver new drugs and therapeutics to patients. With insights from Dr. Harsha Ra...
“Diversity brings better science to the table”
December 16 by Leila HawkinsYusuf Henriques, founder of IndyGeneUS AI, tells Pharma IQ about the need to rethink precision medicine
Five antiviral Covid treatments are too expensive, says UK government body
November 16 by Leila HawkinsUK agency deems treatments too costly, prompting backlash
How big pharma is focusing on diversity, equity and inclusion
November 11 by Leila HawkinsAs Bayer tops list for DEI efforts, we look at how this impacts clinical research
Uganda declares lockdown, Merck to donate vaccine to tackle Ebola
October 26 by Leila HawkinsUganda is trying to contain the latest outbreak of the Sudan variant of Ebola
Top 10 vaccine manufacturers worldwide
October 21 by Leila HawkinsPharma IQ lists the 10 biggest vaccine manufacturers in the world
Meet Pharma IQ’s advisory board: Jennifer Jones-McMeans
October 07 by Leila HawkinsWe speak to Pharma IQ board member Jennifer Jones-McMeans about making clinical trials accessible to underserved communities
First-ever injectable HIV prevention drug to be produced generically
July 28 by Leila HawkinsGeneric versions of new HIV prevention drug to be produced in low and lower-middle income regions
First monkeypox vaccine approved as WHO declares emergency
July 25 by Leila HawkinsBavarian Nordic gets approval for monkeypox vaccine as WHO declares global health emergency
New experimental vaccine for Lou Gehrig’s disease gets EU funding
July 13 by Leila HawkinsThe EU has awarded Intravacc funding for a new vaccine to treat Lou Gehrig’s disease
Natural killer cells: the next frontier for cancer treatment
July 11 by Leila HawkinsPharma IQ speaks to Cytovia Therapeutics about developing the next generation of cancer treatments
Gene silencing: A potential new treatment for rare disease
June 28 by Giles CampionWe look at the latest development in precision medicine: gene silencing